What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.

Karpiak explains how her flexible schedule enables her to succeed at work while staying active in her community.

Novartis investigators find genetic explanations for why some young patients relapse.

Shanelle Gabriel was diagnosed with lupus — a chronic autoimmune disease that mostly affects women of African American and Hispanic descent — while she was at college. Today, as a singer, poet and advocate, she uses her voice to highlight challenges faced by people living with this complex and often misunderstood condition.

Photos: Brent Stirton, Getty Images for Novartis

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.